Cooperative Agreement U2CDK143942
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $882,138 to Baylor College of Medicine to develop the Houston Area Incubator for Kidney, Urologic and Hematologic Research Training (HAI-KUH). This program aims to build a highly qualified workforce to improve the health and quality of life of patients with kidney, urologic, and...
- This $278,893 Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support the development of the "Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)" program. The program aims to create a comprehensive training pathway to recruit, develop, and retain future academic leaders in the fields of kidney, urology, and...
- This Cooperative Agreement award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the NEXT GENERATION KUH RESEARCHERS (GENERATOR) project. The project aims to foster community and collaboration among trainees in the field of kidney, urological, and hematological (KUH) research. With a total funding amount of $368,742 spanning the award period from Sep 1,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $882,138 Project Grant to Mayo Clinic under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "NEXT GENERATION KUH RESEARCHERS (GENERATOR) TRAINING CORE", will fund a research and career development program focused on predoctoral and postdoctoral scholars in kidney, urologic, and hematologic (KUH) research. The 5-year project aims to create a...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $106,395 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The grant, running from September 1, 2025 to August 31, 2030, aims to further the development of individuals into future surgeon-scientists engaged in urology research careers. Key objectives include providing medical...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $414,267 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The goal of this 5-year project, titled "Polycystic Kidney Disease In Vitro Center (PKD-INVENT)", is to expand and enable the preclinical-to-clinical research pathway for polycystic kidney disease (PKD) by generating products, services, and...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $659,182 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Rhode Island Hospital, a division of Lifespan Corporation. The funding will support research to elucidate the role and mechanism of histone deacetylase 6 (HDAC6) in cisplatin-induced kidney injury, fibrosis, and chronic kidney disease, and to identify HDAC6 inhibition as a novel approach for...
- The federal Project Grant award of $237,750 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is supporting a research study to examine nephrology practices' participation decisions and care model reforms under Medicare's Kidney Care Choices payment models. The study, conducted by the Trustees of Indiana University (UEI: SHHBRBAPSM35), aims to better understand how smaller...
- This Project Grant award of $380,625 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to elucidate how the heme metabolite unconjugated bilirubin regulates liver and kidney function in primary human cells and organoids. The research aims to: 1) determine how toxic and beneficial levels of bilirubin are sensed in primary human hepatocytes and kidney...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $316,282 to Baylor College of Medicine to conduct a proof-of-concept trial comparing the feasibility and effectiveness of two medically tailored meals approaches for pediatric patients with end-stage kidney disease (ESKD). The study involves 30 parent-child dyads and will assess the...
The Houston Area Incubator for Kidney, Urologic, and Hematologic (HAI-KUH) Research Training Cooperative Agreement, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), will provide $368,743 to Baylor College of Medicine over a 5-year period from September 1, 2025 to May 31, 2030. The funding will support the development of a professional development program to enhance the skills and competitiveness of pre- and post-doctoral trainees and clinical fellows in the kidney, urologic, and hematologic research fields. Key components include interactive monthly learning sessions, presentation and writing skills development, entrepreneurship/commercialization training, and peer-to-peer mentoring through "HAI-KUH Pods" to improve retention of trainees in academic and non-academic research careers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $368.7k | 8/14/25 |